With $850m, Nuvation Aims To Speed Novel Cancer Drugs To Patients

As With Medivation, David Hung Takes New Venture Public In SPAC Merger

Business growth
Nuvation's growth is powered by veterans of Medivation and other high-profile companies • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Financing

More from Business